BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18610735)

  • 1. New chemotherapy strategies for gastric cancer.
    Kubota T
    In Vivo; 2008; 22(3):273-8. PubMed ID: 18610735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical development of chemotherapy for advanced gastric cancer].
    Sato A; Nakamachi M
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1461-6. PubMed ID: 18799898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical development of oral chemotherapeutic agents for advanced gastric cancer].
    Sato A; Nakamachi M; Imataka H; Hamada K
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1192-7. PubMed ID: 20647697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy options for gastric cancer.
    Meyerhardt JA; Fuchs CS
    Semin Radiat Oncol; 2002 Apr; 12(2):176-86. PubMed ID: 11979419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer].
    Sugimoto N; Narahara H; Sakai D; Yamamoto S; Fumoto S; Yagi T; Imamura F; Iishi H; Tatsuta M
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):417-24. PubMed ID: 19295265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for gastric cancer that recurs after adjuvant chemotherapy with S-1.
    Shitara K; Muro K; Ura T; Takahari D; Yokota T; Sawaki A; Kawai H; Ito S; Yamamura Y
    Jpn J Clin Oncol; 2008 Nov; 38(11):786-9. PubMed ID: 18820010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving chemotherapy for advanced gastric cancer.
    Ajani JA
    Oncologist; 2005; 10 Suppl 3():49-58. PubMed ID: 16368871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on adjuvant MTX-5-FU intraperitoneal chemotherapy for advanced gastric cancer].
    Maruyama M; Nagahama T; Sato E; Maruyama S; Sanada T; Koide A; Ohhinata R; Ebana H
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):1993-5. PubMed ID: 19106501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacogenomics in gastric cancer chemotherapy.
    Nishiyama M; Eguchi H
    Adv Drug Deliv Rev; 2009 May; 61(5):402-7. PubMed ID: 19133303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New insights in the adjuvant treatment of gastric cancer].
    Jansen EP; Boot H; Cats A; van Coevorden F; Zoetmulder FA; Verheij M
    Ned Tijdschr Geneeskd; 2004 Dec; 148(51):2529-34. PubMed ID: 15636473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for locally advanced and metastatic gastric cancer: state of the art and future perspectives.
    Bittoni A; Maccaroni E; Scartozzi M; Berardi R; Cascinu S
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):309-14. PubMed ID: 20496540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer.
    Moehler M; Galle PR; Gockel I; Junginger T; Schmidberger H
    Best Pract Res Clin Gastroenterol; 2007; 21(6):965-81. PubMed ID: 18070698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer.
    Liu TS; Wang Y; Chen SY; Sun YH
    Eur J Surg Oncol; 2008 Nov; 34(11):1208-16. PubMed ID: 18353606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gastrojejunostomy for irresectable gastric cancer with pyloric stenosis-new role of surgery in the era of S-1].
    Matsumoto T; Fujiwara Y; Yamamoto N; Hayashi C; Koishi K; Kojima S; Tanaka J; Kobayashi M; Yamamura T; Miwa H; Tomita N; Sasako M
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):641-5. PubMed ID: 19381039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
    Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in gastric cancer chemotherapy between the East and West.
    Ohtsu A; Yoshida S; Saijo N
    J Clin Oncol; 2006 May; 24(14):2188-96. PubMed ID: 16682738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of AFP producing gastric cancer for which radiation therapy was effective in paraaortic lymph node recurrence].
    Tanizaki K; Nishioka K; Kobayashi K; Igarashi Y; Tsukao Y; Tanida T; Komori T; Matsumoto T; Takachi K; Aoki T; Uemura Y
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2048-50. PubMed ID: 19106519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.
    Wagner AD; Moehler M
    Curr Opin Oncol; 2009 Jul; 21(4):381-5. PubMed ID: 19412098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of advanced gastric cancer treated with chemo-radiotherapy as the fourth-line therapy].
    Imamura H; Furukawa H; Kishimoto T; Miyazaki Y; Ohta K; Yamamoto T; Takemoto H; Fukunaga M; Ohsato H; Tatsuta M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2054-6. PubMed ID: 19106521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.